From: MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features
 | Overall survival (n = 68) | Disease-free survival (n = 58) | ||||||
---|---|---|---|---|---|---|---|---|
 | Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | ||||
 | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value |
miR-181d | 0.51 (0.19-1.41) | 0.20 | 0.42 (0.14-1.23) | 0.11 | 0.60 (0.26-1.41) | 0.25 | 0.34 (0.12-0.94) | 0.04 |
miR-30a-3p | 0.50 (0.20-1.26) | 0.14 | 0.48 (0.19-1.18) | 0.11 | 0.56 (0.27-1.16) | 0.12 | 0.46 (0.21-1.00) | 0.05 |
miR-30c | 0.48 (0.13-1.76) | 0.27 | 0.37 (0.10-1.44) | 0.15 | 0.44 (0.15-1.30) | 0.14 | 0.27 (0.08-0.92) | 0.04 |
miR-30d | 0.33 (0.11-1.06) | 0.06 | 0.25 (0.07-0.82) | 0.02 | 0.41 (0.16-1.08) | 0.07 | 0.33 (0.12-0.90) | 0.03 |
miR-30e-3p | 0.57 (0.20-1.61) | 0.29 | 0.48 (0.17-1.37) | 0.17 | 0.48 (0.20-1.18) | 0.11 | 0.39 (0.16-0.94) | 0.04 |
miR-368 | 1.60 (0.70-3.68) | 0.27 | 1.79 (0.75-4.25) | 0.19 | 0.84 (0.39-1.78) | 0.64 | 0.92 (0.43-1.97) | 0.84 |
miR-370 | 1.25 (0.65-2.39) | 0.51 | 1.83 (0.78-4.31) | 0.17 | 1.23 (0.74-2.06) | 0.43 | 1.77 (0.93-3.34) | 0.08 |
miR-493-5p | 1.16 (0.47-2.84) | 0.75 | 1.51 (0.57-4.00) | 0.41 | 1.27 (0.58-2.77) | 0.55 | 1.70 (0.74-3.94) | 0.21 |
miR-532-5p | 0.89 (0.32-2.52) | 0.83 | 0.84 (0.30-2.36) | 0.74 | 0.84 (0.34-2.07) | 0.70 | 0.69 (0.27-1.74) | 0.43 |